The Journal of
Biomedical Engineering is a national medical academic
journal overseen by the Science and Technology Association of Sichuan Province
and published by West China Hospital of Sichuan University and the Sichuan
Biomedical Engineering Society. First published in 1984, it is a bimonthly
journal released on the 25th of every other month. ISSN: 1001-5515, CN:
51-1258/R; Email code: 62-65; Price: ¥30.00 per issue. Annual subscription
price: ¥180.
Scope and Content
The Journal
covers the latest scientific achievements and technological advancements in
bio-engineering, medical engineering, artificial internal organs, biological
materials, biomechanics, and computational methods. It includes various types
of articles such as commentaries, forums, treatises, new techniques and
methods, and summaries. The journal is particularly attractive to readers
engaged in multidisciplinary research, teaching, production, and technological
management, and is also practical for graduate and undergraduate students
interested in biomedical engineering.
Indexing and Abstracting
The Journal is
systematically recorded in the following databases:
Journals of
Statistic Source of China’s Scientific Research Papers (Key Magazine of
China Technology)
Awarded as
the first session excellent magazine of science and technology journal by
the Science and Technology Information Institute of China in 2008.
Project
based on the national science and technology platform (number:
2005DKA43504).
Awarded as
the third session excellent magazine in 2014 and selected as one of the
100 outstanding Chinese academic journals in 2013.
Awarded the
title of "First-Class Sci-Tech Journal in Sichuan-Chongqing
Region" in 2021.
Selected for
the T2 tier of high-quality sci-tech journals in the field of image and
graphics by the China Association for Science and Technology (CAST) in
2023.
Included in the T2 tier of
high-quality sci-tech journals in the field of biomedical engineering and
selected for CAST’s "Bilingual Communication Project of Sci-Tech
Journals" in 2024.
